MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisThe Role of MicroRNAs in Myeloproliferative NeoplasiaMolecular alterations in gastric cancer with special reference to the early-onset subtypeMicroRNAs and Growth Factors: An Alliance Propelling Tumor ProgressionHypoxamiRs and cancer: from biology to targeted therapyThe significance of genetics for cholangiocarcinoma developmentRole of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknownThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyThe microRNA feedback regulation of p63 in cancer progressionLet-7 microRNA inhibits the proliferation of human glioblastoma cellsModulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancerMicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.miR-221/222 control luminal breast cancer tumor progression by regulating different targets.Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin.miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation.Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus.Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancerMiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaIncreased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cellsAssociation of survivin splice variants with prognosis and treatment of breast cancer.Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-METMicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosisOverexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsmiR-22 represses cancer progression by inducing cellular senescence
P2860
Q21560965-F6D949E3-B93D-4ED4-BB6D-170DB3F560C7Q26739435-B0A36A3E-CD22-4484-B9EE-A4ADDD054F0FQ26764919-A5DFF8C1-0832-47D1-8380-FD3BF2A40FB6Q26796592-8DB822BA-D36B-442B-A7BE-B65B79DB584AQ26863298-E3D8FA47-A14F-4ECC-82FC-51D01568655EQ26865749-4B997767-34DF-4010-83C5-D6AC774A96CDQ27016561-51F00F01-C78A-4CB1-A61A-407FBD9792BCQ28083277-6C4E22B8-5763-4F2F-84D8-DE229EFF619AQ28083742-7E146210-B11B-4208-914D-A29F56C2F910Q28084646-FFB18EC7-0F87-4A9C-AFFA-ABF6FE2F1D8BQ28287254-F53A8F9E-94C1-4229-B499-9F45E4C08BBAQ28729012-89D6618D-C533-497D-89C4-3858D878E0B8Q30010065-016F9343-3183-48AB-87C2-A438134318F5Q30585821-91FDB4AB-7AD2-46CB-AB57-99784571EBB3Q32179591-8C22D352-3B48-4B93-BD34-2BF66E87B9C0Q33649015-6F03B669-B8F4-4C02-95F3-0E6829E12649Q33952998-BF4A5836-E7A4-4113-BF80-715C0BF01A37Q34005444-C59B0F9C-A7FE-47BE-9B0B-8E0022196420Q34048535-CFB46A5A-6DD9-4A7E-A889-2BD8F2C95889Q34160439-EE0D2AC5-C583-4E16-92AA-080F56A6E894Q34195513-860915ED-6018-46D1-8293-33E6A6A4FF48Q34200081-FE60EBB9-A419-40BC-9067-3BDB89132A93Q34221295-2252427C-5AF3-4135-BF34-9AC4B43BB724Q34283327-837927C1-7152-467E-9DAE-940EBF1C6CEEQ34283601-B03AC075-4A36-479A-BF0C-6BDF8C24A631Q34306292-6420D0C5-F23D-4B4A-BB86-D13A0A3787CAQ34309928-7E58021C-60A4-4485-A79E-42C9D4FF58ADQ34405157-F42EC2BF-EB4E-4AB0-800E-29738D299670Q34408265-33EE1B8C-0F43-4BFD-A7B3-5045935B8DC4Q34442762-77A3C498-CF20-448D-B9F3-01C86F85197BQ34485641-89C683A8-DEA0-4016-BD9D-19D21143729DQ34548464-D69E98EB-C5C1-44AB-833F-EF32303646C1Q34638253-75BE2CB6-61DC-4B6D-8CF3-795C59369DDCQ34653749-6B4C2E15-2AF4-43D0-8F39-B6956E6F57A1Q34657717-23700053-681C-45B9-A145-027D61A173D4Q34674537-91DD0EDC-E716-4D59-BC57-7F546C41A72BQ34685896-4F1947AE-8457-4C95-946C-82462E02DAE1Q34745747-716C7535-0A29-46A1-86CC-C321EC92A8C5Q34787505-06D36AEF-35FC-4B8B-88C3-11632C5177D2Q34825182-DDFCE1BD-3304-4F33-9C52-A4C7D15D77C0
P2860
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@en
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@nl
type
label
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@en
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@nl
prefLabel
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@en
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@nl
P1476
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
@en
P2093
Joerg Haier
Richard Hummel
P304
P356
10.1016/J.EJCA.2009.10.027
P577
2009-11-28T00:00:00Z